Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
During treatment with Selumetinib, in addition to its expected therapeutic effects, this medication may cause some adverse effects. While not all side effects occur, some may requi···【more】
Article source：Captain MedicineRelease date：2026-03-10Recommended：5
August 1, 2017 -- The U.S. Food and Drug Administration today approved Enasidenib for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who h···【more】
Article source：Captain MedicineRelease date：2026-03-10Recommended：6
During treatment with Enasidenib, in addition to the expected therapeutic effects, some adverse effects may also occur. While not all side effects happen, some may require medical ···【more】
Article source：Captain MedicineRelease date：2026-03-10Recommended：9
On November 29, 2018, the U.S. Food and Drug Administration (FDA) warned that symptoms of differentiation syndrome, a life-threatening side effect associated with the leukemia drug···【more】
Article source：Captain MedicineRelease date：2026-03-10Recommended：7
Entrectinib is a targeted anticancer drug primarily used to treat solid tumors and lymphomas carrying specific gene mutations. Common side effects include fatigue, dizziness, and c···【more】
Article source：Captain MedicineRelease date：2026-03-09Recommended：11
The price of entrectinib fluctuates due to differences in specifications, purchasing channels, and regions. The price of the original brand-name drug may be higher, while some gene···【more】
Article source：Captain MedicineRelease date：2026-03-09Recommended：10
The price of entrectinib varies depending on factors such as region, medical insurance policies, dosage specifications, and purchasing channels. The specific monthly treatment cost···【more】
Article source：Captain MedicineRelease date：2026-03-09Recommended：15
Entrectinib is a targeted therapy for solid tumors positive for NTRK gene fusions and ROS1-positive non-small cell lung cancer. Its price varies depending on the region, dosage spe···【more】
Article source：Captain MedicineRelease date：2026-03-09Recommended：15
Lucius Pharmaceuticals Osimertinib is a targeted therapy used to treat non-small cell lung cancer. Its common side effects include skin reactions (rash, dryness), gastrointestinal ···【more】
Article source：Captain MedicineRelease date：2026-03-06Recommended：19
The price of Osimertinib varies depending on specifications, region, and medical insurance policies. Currently, the cost per box ranges from thousands to tens of thousands of yuan.···【more】
Article source：Captain MedicineRelease date：2026-03-06Recommended：22
The price of osimertinib varies depending on specifications, region, purchasing channels, and medical insurance policies. For specific prices in the domestic market, it is necessar···【more】
Article source：Captain MedicineRelease date：2026-03-06Recommended：24
Osimertinib is a targeted therapy used to treat specific types of non-small cell lung cancer. Its price in China varies due to factors such as dosage form, purchasing channel, and ···【more】
Article source：Captain MedicineRelease date：2026-03-06Recommended：24
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：1582025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3972024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：1522025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：1712025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：1522025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：1842025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：1652025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：1602025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
